Rhythm Pharmaceuticals Inc (RYTM) financials · rev $189.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Rhythm Pharmaceuticals Inc (RYTM) rev $189.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $189.8M | $130.1M |
| Cost of Revenue | $19.5M | $13.4M |
| Gross Profit | $170.3M | $116.8M |
| Operating Income | -$192.0M | -$265.5M |
| Net Income | -$196.5M | -$260.6M |
| EPS (Diluted) | -$3.11 | -$4.34 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $480.2M | $392.3M |
| Current Assets | $466.9M | $374.2M |
| Cash & Equivalents | $54.3M | $89.1M |
| Inventory | $25.8M | $18.7M |
| PP&E | $1.10M | $632.0K |
| Total Liabilities | $210.2M | $227.7M |
| Current Liabilities | $105.9M | $115.5M |
| Short-term Debt | $7.30M | $1.54M |
| Long-term Debt | $100.9M | $108.3M |
| Total Debt | $108.2M† | $109.8M† |
| Shareholders' Equity | $139.1M | $21.7M |
| Retained Earnings | -$1.35B | -$1.16B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$115.7M | -$113.9M |
| CapEx | $953.0K | N/A |
| Investing Cash Flow | -$137.2M | -$48.2M |
| Financing Cash Flow | $218.0M | $191.2M |
| Net Change in Cash | -$34.8M | $29.2M |
| Free Cash Flow | -$116.6M | -$113.9M |
FAQ
What is RYTM P/E and revenue?
Rhythm Pharmaceuticals Inc (RYTM) rev $189.8M.
What is RYTM revenue?
Rhythm Pharmaceuticals Inc last cached revenue is $189.8M (FY2025).
Is RYTM profitable?
Rhythm Pharmaceuticals Inc last cached net income is -$196.5M (FY2025).
What are RYTM total assets?
Rhythm Pharmaceuticals Inc last cached total assets are $480.2M (FY2025).
What is RYTM free cash flow?
Rhythm Pharmaceuticals Inc last cached free cash flow is -$116.6M (FY2025).
Not investment advice. Cached statements, not a live tape.